CU-CPT4a
CU-CPT4a is a drug which acts as a selective antagonist of Toll-like receptor 3, with an IC50 of 3.44 μM. It is used for research into the function of TRL3 and its role in inflammation, autoimmune disorders and cancer.
CU-CPT4a is a drug which acts as a selective antagonist of Toll-like receptor 3, with an IC50 of 3.44 μM. It is used for research into the function of TRL3 and its role in inflammation, autoimmune disorders and cancer.